These functionalities are explained through a practical example of research of active molecules to the formylpeptide receptor (FPR), a receptor associated with chronic inflammation in systemic amyloidosis and Alzheimer’s disease. Here, FPR1 is linked to early-onset autosomal dominant Alzheimer disease.